DE69415165D1 - Bicyclo (2.2.2) oktan-derivate mit cholecystokinin und/oder gastrin antagonistischer wirkung - Google Patents

Bicyclo (2.2.2) oktan-derivate mit cholecystokinin und/oder gastrin antagonistischer wirkung

Info

Publication number
DE69415165D1
DE69415165D1 DE69415165T DE69415165T DE69415165D1 DE 69415165 D1 DE69415165 D1 DE 69415165D1 DE 69415165 T DE69415165 T DE 69415165T DE 69415165 T DE69415165 T DE 69415165T DE 69415165 D1 DE69415165 D1 DE 69415165D1
Authority
DE
Germany
Prior art keywords
carboxy
halo
group
alkyl
carboxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69415165T
Other languages
English (en)
Inventor
Sarkis Kalindjian
Katherine Steel
Matthew Tozer
Martin Hudson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
James Black Foundation Ltd
Original Assignee
James Black Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James Black Foundation Ltd filed Critical James Black Foundation Ltd
Application granted granted Critical
Publication of DE69415165D1 publication Critical patent/DE69415165D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/86—Ring systems containing bridged rings containing four rings
    • C07C2603/88—Ethanoanthracenes; Hydrogenated ethanoanthracenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
DE69415165T 1993-08-12 1994-08-09 Bicyclo (2.2.2) oktan-derivate mit cholecystokinin und/oder gastrin antagonistischer wirkung Expired - Lifetime DE69415165D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939316722A GB9316722D0 (en) 1993-08-12 1993-08-12 Bicyclo (2.2.2)octane derivatives
PCT/GB1994/001740 WO1995005359A1 (en) 1993-08-12 1994-08-09 Bicyclo (2.2.2) octane derivatives cholecystokinin and/or gastrin antagonists

Publications (1)

Publication Number Publication Date
DE69415165D1 true DE69415165D1 (de) 1999-01-21

Family

ID=10740353

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69415165T Expired - Lifetime DE69415165D1 (de) 1993-08-12 1994-08-09 Bicyclo (2.2.2) oktan-derivate mit cholecystokinin und/oder gastrin antagonistischer wirkung

Country Status (15)

Country Link
EP (1) EP0719251B1 (de)
JP (1) JPH09501438A (de)
AT (1) ATE174327T1 (de)
AU (1) AU689788B2 (de)
CA (1) CA2167156A1 (de)
DE (1) DE69415165D1 (de)
FI (1) FI960571A0 (de)
GB (1) GB9316722D0 (de)
HU (1) HUT74570A (de)
NO (1) NO960467D0 (de)
NZ (1) NZ269826A (de)
PL (1) PL312959A1 (de)
SG (1) SG49638A1 (de)
WO (1) WO1995005359A1 (de)
ZA (1) ZA946087B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998002419A1 (fr) * 1996-07-12 1998-01-22 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de proliferation de cellules cancereuses
WO2004009017A2 (en) * 2002-07-18 2004-01-29 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US7273881B2 (en) 2004-01-16 2007-09-25 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7253283B2 (en) 2004-01-16 2007-08-07 Bristol-Myers Squibb Company Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7625921B2 (en) 2004-01-16 2009-12-01 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7326728B2 (en) 2004-01-16 2008-02-05 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof
US7605264B2 (en) * 2004-01-16 2009-10-20 Bristol-Myers Squibb Company Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7569689B2 (en) * 2004-01-16 2009-08-04 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7317024B2 (en) 2005-01-13 2008-01-08 Bristol-Myers Squibb Co. Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7411071B2 (en) 2005-01-13 2008-08-12 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7642273B2 (en) 2005-01-13 2010-01-05 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7361654B2 (en) 2005-01-13 2008-04-22 Bristol-Myers Squibb Co. Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234264A (en) * 1989-06-29 1993-05-26 Warner Lambert Co N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions
AU2759692A (en) * 1991-10-24 1993-05-21 Glaxo Group Limited Benzodiazepine derivatives as antagonists of gastrin and/or cholecystokinin
JPH07504184A (ja) * 1992-02-20 1995-05-11 ジェイムズ・ブラック・ファウンデーション・リミテッド コレストシストキニン抑制剤としてのビシクロ［２，２，２］オクタン誘導体

Also Published As

Publication number Publication date
NO960467L (no) 1996-02-05
EP0719251B1 (de) 1998-12-09
HUT74570A (en) 1997-01-28
NO960467D0 (no) 1996-02-05
ZA946087B (en) 1996-02-12
EP0719251A1 (de) 1996-07-03
JPH09501438A (ja) 1997-02-10
WO1995005359A1 (en) 1995-02-23
FI960571A (fi) 1996-02-07
FI960571A0 (fi) 1996-02-07
NZ269826A (en) 1996-10-28
AU7347794A (en) 1995-03-14
SG49638A1 (en) 1998-06-15
CA2167156A1 (en) 1995-02-23
HU9600069D0 (en) 1996-03-28
AU689788B2 (en) 1998-04-09
GB9316722D0 (en) 1993-09-29
PL312959A1 (en) 1996-05-27
ATE174327T1 (de) 1998-12-15

Similar Documents

Publication Publication Date Title
DE69415165D1 (de) Bicyclo (2.2.2) oktan-derivate mit cholecystokinin und/oder gastrin antagonistischer wirkung
ES2152989T3 (es) Ligandos para los receptores de gastrina y cck.
AU7087491A (en) Novel benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation, synthesis intermediates and pharmaceutical compositions in which they are present
ATE152095T1 (de) Bicyclo(2.2.2.>oktan derivate als cholestocystokinin harnstoffe
EA199900678A1 (ru) Производные амида гетероарил-гексановой кислоты, их получение и их применение в качестве селективных ингибиторов связывания mip-1-альфа с его рецептором ccr1
IL110151A0 (en) Amide and urea derivatives and pharmaceutical compositions containing the same
ATE156804T1 (de) Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung
HUT68056A (en) Substituted indoles and azaindoles as angiotensin ii antagonists, pharmaceutical compositions containing same, process for their production and intermediates
ES2187565T3 (es) Alcaloides indolicos utiles como agentes antiinflamatorios.
NZ335252A (en) Substituted 3-thia-1,2,3,4-tetrahydrocarbazole, 6,7,8,9-tetrahydropyrido[1,2-a]indole, 4,5-dihydro-thiopyrano[3,4-b]indole, pyrano[3,4-b]indole or beta-carbolinyl derivatives
ATE258438T1 (de) Verwendung von antagonisten des 5-htia rezeptors zur behandlung von harninkontinenz
GB2341861A (en) Substituted imidazole derivatives and their use as histamine H 3 receptor ligands
SE8304545L (sv) Bensamidderivat
ES2096800T3 (es) Benzo(b)tiofen-3-il-piperazinas, un procedimiento para su preparacion y su uso como medicamentos.
ATE505463T1 (de) Benzodiazepin-derivate, verwendbar als cck- rezeptor antagonisten
ES2170802T3 (es) Carboxamidas biciclicas como ligandos de los receptores 5-ht1a.
ATE172458T1 (de) 1,5-benzodiazepin-derivate verwendbar als cck oder gastrin antagonisten

Legal Events

Date Code Title Description
8332 No legal effect for de